Champions Oncology

Quarterly Financials

Values in thousands 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue
$13,995
$12,355
$17,039
$13,489
Gross Profit
-7,995
5,084
10,422
6,417
EBITDA
-527
-2,006
4,916
1,131
EBIT
-2,400
4,518
732
Net Income
-466
-1,834
4,495
728
Net Change In Cash
13,995
12,355
17,039
13,489
Free Cash Flow
554
6,615
448
-377
Cash
10,325
9,785
3,202
2,754
Basic Shares
13,788
13,753
14,364
14,016

Annual Financials

Values in thousands 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Revenue
$56,944
$50,155
$53,870
$49,109
Gross Profit
28,555
20,754
24,338
25,477
EBITDA
6,486
-5,054
-2,069
2,234
EBIT
4,846
-6,921
-5,267
-179
Net Income
4,701
-7,276
-5,335
548
Net Change In Cash
56,944
50,155
53,870
49,109
Cost of Revenue
1,111
4,320
Free Cash Flow
6,997
-6,973
1,083
4,113
Cash
9,785
2,618
10,118
9,007
Basic Shares
14,266
13,547
13,541
14,159

Earnings Calls

Quarter EPS
2025-10-31
$0
2025-07-31
$0.02
2025-04-30
-$0.07
2025-01-31
$0.33